RGN

Regenerx Biopharm In (RGN)

Regenerx Biopharmaceuticals

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:AMEX:RGN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2010/12/22	23:16	Business Wire	First Patient Screened in Phase 2 Trial with RegeneRx’s RGN-259 for Dry Eye Syndrome	AMEX:RGN	Regenerx Biopharmaceuticals
2010/12/22	06:31	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:RGN	Regenerx Biopharmaceuticals
2010/12/21	00:00	Business Wire	RegeneRx’s Scientific Advisory Board Member Receives 2011 Camras Award	AMEX:RGN	Regenerx Biopharmaceuticals
2010/12/10	00:51	Business Wire	RegeneRx Receives Mexican Patent for the Use of TB4 for Prevention and Treatment of Cardiac Damage	AMEX:RGN	Regenerx Biopharmaceuticals
2010/12/02	00:30	Business Wire	RegeneRx Receives Australian Patent Using TB4 to Protect Against Biological, Chemical and Toxic Agents	AMEX:RGN	Regenerx Biopharmaceuticals
2010/12/01	03:41	Business Wire	Researchers Identify Potential Thymosin Beta 4 Receptor	AMEX:RGN	Regenerx Biopharmaceuticals
2010/11/17	23:35	Business Wire	RegeneRx Receives Australian Patent Using Tβ4 for Treatment Of Gastrointestinal Disorders	AMEX:RGN	Regenerx Biopharmaceuticals
2010/11/17	04:30	Business Wire	RegeneRx President and CEO to Present at Maxim Group Growth Conference	AMEX:RGN	Regenerx Biopharmaceuticals
2010/11/12	20:09	Edgar (US Regulatory)	Quarterly Report (10-Q)	AMEX:RGN	Regenerx Biopharmaceuticals
2010/11/02	20:30	Business Wire	RegeneRx Reports Positive Results of Preclinical Dry Eye Study	AMEX:RGN	Regenerx Biopharmaceuticals
2010/11/02	06:06	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:RGN	Regenerx Biopharmaceuticals
2010/11/02	05:30	Business Wire	RegeneRx Receives Non-compliance Notice from NYSE Amex; Intends to Request Hearing	AMEX:RGN	Regenerx Biopharmaceuticals
2010/11/02	01:56	Business Wire	RegeneRx Awarded $733,438 from U.S. Government Under the Patient Protection and Affordable Care Act	AMEX:RGN	Regenerx Biopharmaceuticals
2010/10/27	00:07	Business Wire	RegeneRx Announces Letter to Stockholders Posted on Website	AMEX:RGN	Regenerx Biopharmaceuticals
2010/09/14	22:08	Business Wire	RegeneRx Announces TB4 Stroke Study to be Honored at American Heart Association Scientific Sessions	AMEX:RGN	Regenerx Biopharmaceuticals
2010/09/07	23:35	Business Wire	RegeneRx President and CEO to Speak at Rodman & Renshaw Annual Global Investment Conference	AMEX:RGN	Regenerx Biopharmaceuticals
2010/09/04	06:41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:RGN	Regenerx Biopharmaceuticals
2010/09/04	06:22	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	AMEX:RGN	Regenerx Biopharmaceuticals
2010/09/02	21:44	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:RGN	Regenerx Biopharmaceuticals
2010/09/02	20:00	Business Wire	RegeneRx Appoints R. Don Elsey to Board of Directors	AMEX:RGN	Regenerx Biopharmaceuticals
2010/08/21	05:01	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	AMEX:RGN	Regenerx Biopharmaceuticals
2010/08/13	19:02	Edgar (US Regulatory)	Quarterly Report (10-Q)	AMEX:RGN	Regenerx Biopharmaceuticals
2010/08/02	21:30	Business Wire	British Researchers Report that TB4 is Essential to Heart Development	AMEX:RGN	Regenerx Biopharmaceuticals
2010/07/22	05:48	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (S-8)	AMEX:RGN	Regenerx Biopharmaceuticals
2010/07/21	06:26	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:RGN	Regenerx Biopharmaceuticals
2010/07/20	01:30	Business Wire	Researchers Report in Neuroscience that TB4 Improves Neurological Function after Stroke	AMEX:RGN	Regenerx Biopharmaceuticals
2010/07/17	06:35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:RGN	Regenerx Biopharmaceuticals
2010/07/17	06:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:RGN	Regenerx Biopharmaceuticals
2010/07/17	06:29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:RGN	Regenerx Biopharmaceuticals
2010/07/17	06:25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:RGN	Regenerx Biopharmaceuticals